Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects and Grants
- 2 Finished
-
Impact of early antiretroviral therapy on kidney disease outcomes
DUKE UNIVERSITY, NATIONAL INSTITUTES OF HEALTH (NIH)
7/1/18 → 6/30/23
Project: Research project
-
Impact of early antiretroviral therapy on kidney disease
CEDARS-SINAI MEDICAL CENTER, NATIONAL INSTITUTES OF HEALTH (NIH)
9/1/17 → 6/30/18
Project: Research project
-
Rate of response to initial antiretroviral therapy according to level of pre-existing HIV-1 drug resistance detected by next-generation sequencing in the strategic timing of antiretroviral treatment (START) study
Cozzi-Lepri, A., Dunn, D., Tostevin, A., Marvig, R. L., Bennedbæk, M., Sharma, S., Kozal, M. J., Gompels, M., Pinto, A. N., Lundgren, J. & Baxter, J. D., Feb 2024, In: HIV Medicine. 25, 2, p. 212-222 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Investigation of Causal Effects of Protein Biomarkers on Cardiovascular Disease in Persons With HIV
Reilly, C. S., Borges, Á. H., Baker, J. V., Safo, S. E., Sharma, S., Polizzotto, M. N., Pankow, J. S., Hu, X., Sherman, B. T., Babiker, A. G., Lundgren, J. D. & Lane, H. C., Apr 15 2023, In: Journal of Infectious Diseases. 227, 8, p. 951-960 10 p.Research output: Contribution to journal › Article › peer-review
-
Cytomegalovirus viremia and risk of disease progression and death in HIV-positive patients starting antiretroviral therapy
Levi, L. I., Sharma, S., Schleiss, M. R., Furrer, H., Nixon, D. E., Blackstad, M., Hernandez-Alvarado, N., Dwyer, D. E., Borges, A. H., Lane, H. C., Lundgren, J., Neaton, J. D. & Molina, J. M., Jul 15 2022, In: AIDS. 36, 9, p. 1265-1272 8 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)
Murray, D. D., Babiker, A. G., Baker, J. V., Barkauskas, C. E., Brown, S. M., Chang, C. C., Davey, V. J., Gelijns, A. C., Ginde, A. A., Grund, B., Higgs, E., Hudson, F., Kan, V. L., Lane, H. C., Murray, T. A., Paredes, R., Parmar, M. K. B., Pett, S., Phillips, A. N., Polizzotto, M. N., & 8 others , Feb 2022, In: Clinical Trials. 19, 1, p. 52-61 10 p.Research output: Contribution to journal › Article › peer-review
12 Scopus citations -
Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial
ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group, May 2022, In: The Lancet Infectious Diseases. 22, 5, p. 622-635 14 p.Research output: Contribution to journal › Article › peer-review
Open Access129 Scopus citations